Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bioatla Inc (NQ: BCAB )

1.790 -0.030 (-1.65%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 28, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 188,281
Open 1.830
Bid (Size) 1.710 (2)
Ask (Size) 1.910 (1)
Prev. Close 1.820
Today's Range 1.750 - 1.905
52wk Range 1.670 - 11.73
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Analyst Ratings for BioAtla
Via Benzinga
BioAtla to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
From BioAtla, Inc.
Via GlobeNewswire

Performance

YTD
-77.85%
-77.85%
1 Month
-28.69%
-28.69%
3 Month
-38.06%
-38.06%
6 Month
-28.69%
-28.69%
1 Year
-77.31%
-77.31%

More News

Read More
BioAtla to Participate in Upcoming Investor Conferences in August
From BioAtla, Inc.
Via GlobeNewswire
The Latest Analyst Ratings for BioAtla
Via Benzinga
BioAtla Reports Second Quarter 2023 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
Where BioAtla Stands With Analysts
Via Benzinga
Expert Ratings for BioAtla
Via Benzinga
Earnings Outlook For BioAtla
Via Benzinga
BioAtla to Announce Second Quarter 2023 Financial Results and Provide Business Highlights on August 1, 2023
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Added to Membership of U.S. Small-Cap Russell 2000® Index
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Participate in the Jefferies Healthcare Conference
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Reports First Quarter 2023 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Participate in the JMP Securities Life Sciences Conference
From BioAtla, Inc.
Via GlobeNewswire
BioAtla to Announce First Quarter 2023 Financial Results and Provide Business Highlights on May 11, 2023
From BioAtla, Inc.
Via GlobeNewswire
Around $1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Via Benzinga
BioAtla Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Progress
From BioAtla, Inc.
Via GlobeNewswire
Earnings Scheduled For March 23, 2023
Via Benzinga
BioAtla to Announce Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Highlights
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Announces Change in Executive Leadership
From BioAtla, Inc.
Via GlobeNewswire
BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of Advanced Adenocarcinoma
From BioAtla, Inc.
Via GlobeNewswire
Dow Rises Over 100 Points; Rayonier Advanced Materials Shares Plunge
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Crude Oil Rises Over 1%; Oak Street Health Shares Spike Higher
Via Benzinga
US Stocks Open Higher; Nasdaq Rises 50 Points
Via Benzinga
BioAtla Provides Clinical Program Updates and Upcoming 2023 Milestones
From BioAtla, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.